Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Edgemont Pharmaceuticals obtains license to market CPI-300 in U.S.

Feb. 16, 2012

NIH to fund development of next-generation biodefense vaccines

Feb. 16, 2012

Newron and Meiji Seika Pharma finalize licensing agreement

Feb. 15, 2012

Columbia Laboratories transfers progesterone vaginal gel NDA

Feb. 15, 2012

Compendia Bioscience enters partnership for next-generation cancer therapeutics

Feb. 15, 2012

BioDiem grants exclusive license for LAIV vaccine technology

Feb. 14, 2012

UCB Pharma enters collaboration with Nodality

Feb. 13, 2012

Advinus Therapeutics and Celgene Global Health enter collaboration

Feb. 13, 2012

Zalicus and Hydra Biosciences to collaborate on ion channel modulators

Feb. 13, 2012

Vernalis and Tris Pharma enter licensing agreement

Feb. 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...